Electrocardiographic and Hemodynamic Effects of a Multicomponent Dietary Supplement Containing Ephedra and Caffeine
Author(s) -
Brian F. McBride,
Angeliki K. Karapanos,
Agnes Krudysz,
Jeffrey Kluger,
Craig I Coleman,
C Michael White
Publication year - 2004
Publication title -
jama
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 4.688
H-Index - 680
eISSN - 1538-3598
pISSN - 0098-7484
DOI - 10.1001/jama.291.2.216
Subject(s) - medicine , placebo , qt interval , crossover study , caffeine , confidence interval , blood pressure , adverse effect , anesthesia , cardiology , alternative medicine , pathology
Metabolife 356, a multicomponent dietary supplement containing ephedra and caffeine (DSEC) in addition to several other components, is the top-selling dietary weight loss supplement. Given its common use, anecdotal reports of cardiovascular and cerebrovascular adverse events, and paucity of safety data, further research with this DSEC was warranted.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom